Take for instance, targeting histone methyltransferase EZH2 (zeste homolog 2) significantly alleviates intestinal inflammation, EZH2 is correlated with colorectal cancer stage and prognosis, linked to CRC tumorigenesis11–13. This evidence concerns the gene EZH2 and colorectal carcinoma.